Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
Thu, May 24, 2012
Wed, May 23, 2012
[ Wed, May 23rd 2012 ] - Market Wire
Moody's Upgrades Mylan
Tue, May 22, 2012
Mon, May 21, 2012

ShangPharma Corporation Issues Statement in Response to Name Confusion


//health-fitness.news-articles.net/content/2012/ .. ues-statement-in-response-to-name-confusion.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


ShangPharma Corporation Issues Statement in Response to Name Confusion -- SHANGHAI, May 29, 2012 /PRNewswire-Asia/ --

ShangPharma Corporation Issues Statement in Response to Name Confusion

[ ]

SHANGHAI, May 29, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: [ SHP ]) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today issued a statement to clarify potential market confusion between the name of the Company and Shanghai Pharmaceuticals Holdings Co., Ltd. (2607.HK, 601607.SH).

"To clarify any confusion in the market, ShangPharma has no affiliation with Shanghai Pharmaceuticals Holdings Co., Ltd.," the Company stated. "While the names are similar in English, the Chinese character 'Shang' in ShangPharma is different than the character in 'Shanghai Pharmaceuticals Holdings Co., Ltd. '"

ABOUT SHANGPHARMA CORPORATION

ShangPharma Corporation (NYSE: [ SHP ]) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit [ www.shangpharma.com ].

For further information, please contact:

ShangPharma
Ms. Lan Xie
VP of Finance and Investor Relations
Email: [ ir@shangpharma.com ]

Brunswick Group
Mr. Josh Gartner
Email: [ shangpharma@brunswickgroup.com ]
Phone: 86-10-5960-8600

SOURCE ShangPharma Corporation

[ Back to top ]

RELATED LINKS
[ http://www.shangpharma.com ]


Publication Contributing Sources